Eicosapentaenoic acid as the gold standard for patients with peripheral artery disease?: - Subanalysis of the jelis trial -

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1298-1299

  Yamanouchi, Dai ^a,b   Komori, Kimihiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID;

ANGIOPLASTY; ARTERY DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; CLINICAL PROTOCOL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EDITORIAL; GOLD STANDARD; HEART DEATH; HEART INFARCTION; HUMAN; MORTALITY; RISK FACTOR; SECONDARY PREVENTION; STENT; UNSTABLE ANGINA PECTORIS; JAPAN; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EICOSAPENTAENOIC ACID; HUMANS; JAPAN; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77954518965     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0449     Document Type: Editorial

References (12)

1. Ishikawa Y, Yokoyama M, Saito Y, Matsuzaki M, Origasa H, Oikawa S, et al for the JELIS Investigators, Japan. Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease: Subanalysis of the JELIS Trial. Circ J 2010; 74: 1451-1457.
2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-743.
3. Daskalopoulou SS, Pathmarajah M, Kakkos SK, Daskalopoulos ME, Holloway P, Mikhailidis DP, et al. Association between antebrachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 2008; 72: 441-448.
4. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 1996; 94: 3026-3049.
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5-S67.
6. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-1717.
7. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-1098.
8. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006; 113: 195-202.
9. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA 2006; 296: 1885-1899.
10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Pre-venzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-455.
11. McElduff P, Jaefarnezhad M, Durrington PN. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart 2006; 92: 1213-1218.
12. Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes 2009; 2: 616-623.